Precision Medicine

Sarepta Therapeutics Stock Climbed 80% on Spectacular DMD Therapy Update

June 21, 2018

Sarepta Therapeutics shares rocketed by as much as 80 percent yesterday after the company released interim data on its experimental gene therapy AAVrh74.MHCK7.micro-Dystrophin for Duchenne muscular dystrophy (DMD).   DMD is a muscle wasting disease caused by mutations in the dystrophin gene. It is a progressive disease that usually causes death in early adulthood, with […]

Gene Editing Tool May Raise Cancer Risk In Cells, Scientists Warn

June 14, 2018

LONDON (Reuters) – A gene-editing technology that is being explored by scientists worldwide as a way of removing and replacing gene defects might inadvertently increase cancer risk in cells, scientists warned on Monday. Researchers from the Britain’s Cambridge University and Sweden’s Karolinska Institute said more research needs to be done to assess whether using CRISPR-Cas9 […]

Could an old Amgen-developed RA drug make CAR-T treatments safer?

June 7, 2018

The personalized CAR-T cells that are FDA-approved to treat blood cancers, Gilead’s Yescarta and Novartis’s Kymriah, can raise the risk of a side effect that has been challenging to prevent and treat: cytokine release syndrome (CRS).   The frightening collection of symptoms CRS can cause range from rash and fever to severe neurological problems. Oncologists […]

72% of Life Science Professionals Believe Their Industry is Behind in the Development of AI, Finds Survey from The Pistoia Alliance

June 7, 2018

Life science professionals highlight technology and healthcare as collaboration priorities for ensuring successful application of AI   A survey of 229 life science professionals from The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, has found the majority (72%) believe their sector is lagging […]

Following historical budget allocation, Canada enters BIO 2018 with thriving life science industry

June 6, 2018

Following historical budget allocation, Canada enters BIO 2018 with thriving life science industry Contact: Brendan Monahan Rasky Partners, Inc. bmonahan@rasky.com 413-537-4063 Boston, Ma (June 1st, 2018) –The size and prominence of the Canadian delegation arriving at BIO 2018 – among the largest international delegation – demonstrates the tremendous success that the government’s record setting investment […]

Enhance Precision Oncology Trial Success

June 4, 2018

As the complexity of precision oncology trials increase, drug developers are facing the paradox of patient scarcity in the presence of data abundance. Using the right technologies can help to solve this paradox. Read our white paper to learn more.  

Cystic Fibrosis Therapeutics Market: Global Industry Insights and CAGR Analysis 2018 – 2024 with Major Key Vendors – Genentech, Novartis, Gilead Sciences, AbbVie, GlaxoSmithKline

March 21, 2018

Marketprognosis.com Publish a New Market Research Report On “Cystic Fibrosis Therapeutics Market Global Forecast to 2024” which contains global key player’s survey information and forecast to 2024. Overview of the Global Cystic Fibrosis Therapeutics Market: The market for Cystic Fibrosis Therapeutics is anticipated to grow with double digit CAGR during the forecasting period. Cystic fibrosis […]

Nightingale Health and THL Biobank to accelerate personalized medicine by analyzing 40,000 blood samples

March 12, 2018

Nightingale Health, the Finnish innovator of an internationally recognized biomarker testing technology for chronic disease screening, will analyze 40,000 blood samples from Finland’s largest biobank, THL Biobank, acting under the National Institute for Health and Welfare (THL). This initiative signifies a step towards bringing personalized medicine to Finnish healthcare. Until recently, prohibitive costs and time […]

FEEDBACK